# Yulei Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yulei-wang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,819 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 46 |
| i10-index | 77 |
| OpenAlex ID | https://openalex.org/A5100374615 |
| ORCID iD | https://orcid.org/0000-0002-9057-9786 |
| Works | 171 |

## Researcher papers

- [Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study](https://scholariq.org/papers/atezolizumab-with-or-without-bevacizumab-in-unresectable-hepatocellular/)
- [Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/atezolizumab-plus-bevacizumab-versus-active-surveillance-in-patients-with/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Molecular Biology Techniques and Applications](https://scholariq.org/topics/molecular-biology-techniques-and-applications/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.